Related Experiment Video
Updated: Jul 15, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Discovery and development of therapeutic cancer vaccines
Bruce Acres1, Jean-Marc Limacher, Jeanoy Bonnefoy
1Transgene SA, Department of Medical Affairs, 11 rue de Molsheim, 67082 Strasbourg, France. acres@transgene.fr
Abstract:
Over the past century, various efforts have been made to induce the rejection of cancerous tissues by the stimulation of an immune reaction, using both non-specific and antigen-specific strategies. Non-specific approaches attempt to augment an immune response in and around the tumor by injecting immune stimulating substances, for example, bacterial extracts, cytokines or gene therapy agents. Antigen-specific approaches use either the tumor cells themselves as a source of antigens or incorporate identified tumor-associated antigens into vaccines. This review describes antigen-specific therapeutic cancer vaccines that are currently in development.
Insights
Cancer vaccines aim to trigger immune responses against tumors using specific targets. This review focuses on antigen-specific therapeutic cancer vaccines currently under development for cancer treatment.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Over a century, cancer treatment has explored immune stimulation for tissue rejection.
- Strategies include non-specific immune augmentation and antigen-specific approaches.
- Non-specific methods involve injecting immune-stimulating substances near tumors.
Purpose of the Study:
- This review focuses on antigen-specific therapeutic cancer vaccines.
- It describes vaccines currently in development for cancer treatment.
Main Methods:
- Review of antigen-specific therapeutic cancer vaccines.
- Analysis of strategies utilizing tumor cells or tumor-associated antigens.
Main Results:
- Antigen-specific vaccines leverage tumor cells or identified antigens.
- Various antigen-specific therapeutic cancer vaccines are in development.
Conclusions:
- Antigen-specific cancer vaccines represent a key area of therapeutic development.
- These vaccines aim to harness the immune system for targeted cancer rejection.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

